Global Markets on Infectious Diseases
Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.
- Mechanism of action of virus
- Prevention and control of virus
- Rabies
- Malaria, Dengue fever, River blindness
- Available vaccines
Related Conference of Global Markets on Infectious Diseases
12th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
20th International Conference on Allergic Diseases and Clinical Immunology
6th International conference on Vaccines, Vaccination and Immunization
Global Markets on Infectious Diseases Conference Speakers
Recommended Sessions
- Immunology of Infections
- Advancements in Vaccines and Therapeutics
- Antimicrobials/Antibiotics/Antibacterial
- Bacterial Infectious Diseases
- Blood infectious Diseases
- Dental and Oral Infectious Diseases
- Ebola and Zika Viral Infections
- Fungal Infectious Diseases
- Global Markets on Infectious Diseases
- HIV/AIDS and Sexually Transmitted Infections
- Infection Control And Public Health Awareness
- Infectious Diseases
- Infectious Diseases Epidemiology
- Molecular Diagnosis and Treatment of Infectious Diseases
- Most Common NTDs Causes and Treatments
- Neglected Tropical Diseases
- Neuro Infectious Diseases
- Nosocomial Infections & Control
- Pediatric Infectious Diseases
- Tropical Medicine and Immunization Vaccination
- Veterinary Infectious Diseases
- Viral Infectious Diseases
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Animal Models & Clinical Trials - Vaccines-Immunization-2025 (France)
- Antibiotic Prophylaxis - Antibiotics 2025 (France)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2025 (France)
- Antibiotic-resistant Bacterial infections - Antibiotics 2025 (France)
- Antibiotics - Antibiotics 2025 (France)
- Antibiotics for Various Diseases and Infections - Antibiotics 2025 (France)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2025 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2025 (France)
- Antimicrobial Peptides - Antibiotics 2025 (France)
- Antimicrobial Therapy - Antibiotics 2025 (France)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Italy)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Italy)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2025 (France)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Italy)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2025 (France)
- Clinical Trials of Antibiotics - Antibiotics 2025 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2025 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2025 (France)
- Current research in antibiotic resistance - Antibiotics 2025 (France)
- Developing Alternatives to Antibiotics - Antibiotics 2025 (France)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (France)
- Different Types of Antibiotics - Antibiotics 2025 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2025 (France)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2025 (France)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Italy)
- Epidemiology - European Immunology 2025 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2025 (France)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- Geriatric Immunization - Vaccines-Immunization-2025 (France)
- HIV Vaccines - Vaccines-Immunization-2025 (France)
- Immune System - European Immunology 2025 (France)
- Immunodeficiency - European Immunology 2025 (France)
- Immunogenetics - European Immunology 2025 (France)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (France)
- Immunological Techniques - European Immunology 2025 (France)
- Immunology - European Immunology 2025 (France)
- Immunology & Vaccines - Antibiotics 2025 (France)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Italy)
- Immunotherapy - European Immunology 2025 (France)
- Immunotoxicology - European Immunology 2025 (France)
- Infectious Diseases - Antibiotics 2025 (France)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Italy)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics 2025 (France)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2025 (France)
- Microorganisms Producing Antibiotics - Antibiotics 2025 (France)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology - European Immunology 2025 (France)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Italy)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Italy)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Italy)
- Parasite Immunology - European Immunology 2025 (France)
- Peadiatric Vaccination - Vaccines-Immunization-2025 (France)
- Pediatrics Immunology - European Immunology 2025 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2025 (France)
- Pharmacology & Toxicology - Antibiotics 2025 (France)
- Reproductive Immunology - European Immunology 2025 (France)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Italy)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Italy)
- The Next Generation Approach of Antibiotics - Antibiotics 2025 (France)
- Transplantation Immunology - European Immunology 2025 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2025 (France)
- Vaccine Production & Development - Vaccines-Immunization-2025 (France)
- Vaccines - Vaccines-Immunization-2025 (France)
- Vaccines & Autism - Vaccines-Immunization-2025 (France)
- Vaccines against Drugs - Vaccines-Immunization-2025 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2025 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2025 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2025 (France)
- Viral Immunology - European Immunology 2025 (France)